Stay updated on KarXT for Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for the Phase 3 KarXT study in psychosis associated with Alzheimer’s disease is now displayed, including its study design, eligibility criteria, outcomes, and contact details. The record also lists recruiting locations and provides information about sharing anonymized participant data.SummaryDifference100%

- Check13 days agoChange DetectedThe footer's site revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedAn NIH-wide notice about the website transition and terminology appears above the ClinicalTrials.gov 403 error page. The footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe site's footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record content and navigation with an access-denied message.SummaryDifference20%

- Check62 days agoChange DetectedThe header text changed capitalization from 'Find Contact Information' to 'Find contact information'. The footer revision label updated from 'Revision: v3.6.6' to 'Revision: v3.7.0', indicating a minor version update.SummaryDifference0.0%

Stay in the know with updates to KarXT for Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.